Improvement in postoperative pain control by combined use of intravenous dexamethasone with intravenous dexmedetomidine after interscalene brachial plexus block for arthroscopic shoulder surgery: A randomised controlled trial
European Journal of Anaesthesiology Apr 08, 2019
Kang RA, et al. - In this randomised controlled study, researchers compared combined use of intravenous dexamethasone and intravenous dexmedetomidine vs intravenous dexamethasone alone, in terms of time to first rescue analgesic request, in 66 patients undergoing arthroscopic shoulder surgery with single-shot interscalene brachial plexus block (ISBPB). Using random assignment, participants received either intravenous 0.9% saline (control), or intravenous dexamethasone 0.11 mg kg−1 (D1 group), or co-administered intravenous dexamethasone 0.11 mg kg−1 and intravenous dexmedetomidine 1.0 μg kg−1 (D2 group). Findings revealed that time to first rescue analgesic request after single-shot ISBPB was significantly prolonged in patients who received co-administered intravenous dexamethasone (0.11 mg kg−1) with dexmedetomidine (1.0 μg kg−1).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries